[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"news-aggregator-william-blair-forecasts-genmab330195948d-9073-7698-a114-63299a20b5e3":3},{"id":4,"timestamp":5,"title":6,"content":7,"link":8,"preview":9,"tags":10,"predictedTags":11,"showTags":12,"source":13,"reactions":14,"selfReactions":15,"logo":16,"sourceId":17,"sourceUserId":18,"asset":19,"tagsCategories":20,"totalComments":21,"lang":22,"unique_views_count":21,"enrichStatus":19},"william-blair-forecasts-genmab330195948d-9073-7698-a114-63299a20b5e3","1741952653000","William Blair Forecasts Genmab A/S FY2029 Earnings","Genmab A/S (NASDAQ:GMAB - Free Report) - Research analysts at  William Blair issued their FY2029 earnings per share (EPS) estimates for Genmab A/S  in a research report issued on  Monday, March 10th. William Blair analyst M. Phipps anticipates that the company will earn $4.38 per share for the year.","https://www.marketbeat.com/instant-alerts/william-blair-forecasts-genmab-as-fy2029-earnings-2025-03-13/","https://www.marketbeat.com/images/marketbeat-logo-1200-1200.jpg?v=1","[]","[\"\",\"-\"]","[{\"name\":\"\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/blockchains/.png\"},{\"name\":\"-\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/protocols/-.png\"}]","33",[],[],"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/news-feeds/sources/market-beat.png","Market Beat",null,"","[\"Other\"]","0","EN"]